NewEdge Advisors’s VolitionRx Ltd VNRX Stock Holding History

NewEdge Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10	Closed	-$138	–	3885
2023 Q3	$138	Sell	10 -25	-71%	-$618	﹤0.01%	3346
2023 Q2	$973	Sell	35 -6	-15%	-$197	﹤0.01%	3248
2023 Q1	$1.55K	Hold	41	–	–	﹤0.01%	3086
2022 Q4	$2	Buy	+41	New	+$1.59K	﹤0.01%	3964
2021 Q3	–	Sell	-756	Closed	-$50K	–	1230
2021 Q2	$50K	Sell	756 -94	-11%	-$6.36K	﹤0.01%	1119
2021 Q1	$64K	Buy	+850	New	+$72.9K	﹤0.01%	1010

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

NewEdge Advisors's VNRX Position: Q4 2023 in Review

NewEdge Advisors sold out of VolitionRx Ltd (VNRX) in Q4 2023, closing a stake of 10 shares — an estimated $138 sold.

NewEdge Advisors first reported a position in VNRX in Q1 2021 and held it in 6 quarters. The position peaked at $64K in Q1 2021. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2023.

NewEdge Advisors reported no remaining VolitionRx Ltd position as of Q4 2023 after selling out during the quarter.
NewEdge Advisors sold 10 VolitionRx Ltd shares in Q4 2023, an estimated $138.
NewEdge Advisors first reported a position in VolitionRx Ltd in Q1 2021 and held it in 6 quarters.
NewEdge Advisors's VolitionRx Ltd position peaked at $64K in Q1 2021.
28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2023.

Based on NewEdge Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.